231 related articles for article (PubMed ID: 21399657)
21. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
[TBL] [Abstract][Full Text] [Related]
22. Oxytocin receptor induces mammary tumorigenesis through prolactin/p-STAT5 pathway.
Li D; San M; Zhang J; Yang A; Xie W; Chen Y; Lu X; Zhang Y; Zhao M; Feng X; Zheng Y
Cell Death Dis; 2021 Jun; 12(6):588. PubMed ID: 34099636
[TBL] [Abstract][Full Text] [Related]
23. Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer.
Park S; Willingham MC; Qi J; Cheng SY
Endocr Relat Cancer; 2018 Oct; 25(10):865-877. PubMed ID: 29914872
[TBL] [Abstract][Full Text] [Related]
24. Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1).
Fozzatti L; Lu C; Kim DW; Park JW; Astapova I; Gavrilova O; Willingham MC; Hollenberg AN; Cheng SY
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17462-7. PubMed ID: 21987803
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.
Fozzatti L; Park JW; Zhao L; Willingham MC; Cheng SY
PLoS One; 2013; 8(6):e67954. PubMed ID: 23840792
[TBL] [Abstract][Full Text] [Related]
26. Extranuclear signaling of mutated thyroid hormone receptors in promoting metastatic spread in thyroid carcinogenesis.
Lu C; Cheng SY
Steroids; 2011 Aug; 76(9):885-91. PubMed ID: 21473875
[TBL] [Abstract][Full Text] [Related]
27. Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling.
O'Shea PJ; Kim DW; Logan JG; Davis S; Walker RL; Meltzer PS; Cheng SY; Williams GR
J Biol Chem; 2012 May; 287(21):17812-17822. PubMed ID: 22442145
[TBL] [Abstract][Full Text] [Related]
28. Knock-in mouse model for resistance to thyroid hormone (RTH): an RTH mutation in the thyroid hormone receptor beta gene disrupts cochlear morphogenesis.
Griffith AJ; Szymko YM; Kaneshige M; Quiñónez RE; Kaneshige K; Heintz KA; Mastroianni MA; Kelley MW; Cheng SY
J Assoc Res Otolaryngol; 2002 Sep; 3(3):279-88. PubMed ID: 12382103
[TBL] [Abstract][Full Text] [Related]
29. Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis.
Mapes J; Anandan L; Li Q; Neff A; Clevenger CV; Bagchi IC; Bagchi MK
J Biol Chem; 2018 Feb; 293(8):2850-2864. PubMed ID: 29321207
[TBL] [Abstract][Full Text] [Related]
30. Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors.
Tikoo A; Roh V; Montgomery KG; Ivetac I; Waring P; Pelzer R; Hare L; Shackleton M; Humbert P; Phillips WA
PLoS One; 2012; 7(5):e36924. PubMed ID: 22666336
[TBL] [Abstract][Full Text] [Related]
31. Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor.
Furuya F; Hanover JA; Cheng SY
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1780-5. PubMed ID: 16446424
[TBL] [Abstract][Full Text] [Related]
32. Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
Lu C; Zhao L; Ying H; Willingham MC; Cheng SY
Endocrinology; 2010 Apr; 151(4):1929-39. PubMed ID: 20133453
[TBL] [Abstract][Full Text] [Related]
33. Novel functions of thyroid hormone receptor mutants: beyond nucleus-initiated transcription.
Furuya F; Ying H; Zhao L; Cheng SY
Steroids; 2007 Feb; 72(2):171-9. PubMed ID: 17169389
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice.
Zimonjic DB; Kato Y; Ying H; Popescu NC; Cheng SY
Cancer Genet Cytogenet; 2005 Sep; 161(2):104-9. PubMed ID: 16102579
[TBL] [Abstract][Full Text] [Related]
35. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
Peng M; Ball-Kell SM; Tyner AL
Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
[TBL] [Abstract][Full Text] [Related]
36. Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progression.
Ying H; Furuya F; Zhao L; Araki O; West BL; Hanover JA; Willingham MC; Cheng SY
J Clin Invest; 2006 Nov; 116(11):2972-84. PubMed ID: 17039256
[TBL] [Abstract][Full Text] [Related]
37. Hyperactivity, impaired learning on a vigilance task, and a differential response to methylphenidate in the TRbetaPV knock-in mouse.
Siesser WB; Cheng SY; McDonald MP
Psychopharmacology (Berl); 2005 Oct; 181(4):653-63. PubMed ID: 15983791
[TBL] [Abstract][Full Text] [Related]
38. PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis.
Belguise K; Sonenshein GE
J Clin Invest; 2007 Dec; 117(12):4009-21. PubMed ID: 18037997
[TBL] [Abstract][Full Text] [Related]
39. Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.
Zhao D; Ma G; Zhang X; He Y; Li M; Han X; Fu L; Dong XY; Nagy T; Zhao Q; Fu L; Dong JT
J Biol Chem; 2016 Jun; 291(24):12809-12820. PubMed ID: 27129249
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
Furuya F; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]